fluconazole has been researched along with Infection, Mycobacterium avium-intracellulare in 12 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review rifabutin-associated uveitis and discuss the mechanism and potential role of drug interactions with clarithromycin and fluconazole in contributing to this adverse event." | 4.79 | Rifabutin-associated uveitis. ( Tseng, AL; Walmsley, SL, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (91.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jariwala, S | 1 |
| Vernon, N | 1 |
| de Vos, G | 1 |
| Narang, PK | 1 |
| Trapnell, CB | 1 |
| Schoenfelder, JR | 1 |
| Lavelle, JP | 1 |
| Bianchine, JR | 1 |
| Fuller, JD | 1 |
| Stanfield, LE | 1 |
| Craven, DE | 1 |
| Tseng, AL | 1 |
| Walmsley, SL | 1 |
| Schimkat, M | 1 |
| Althaus, C | 1 |
| Becker, K | 1 |
| Sundmacher, R | 1 |
| Brettle, RP | 1 |
| Cheng, B | 1 |
| Wood, D | 1 |
| Bowersox, J | 1 |
| Schouten, JT | 1 |
| Whittemore, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole and Dapsone and Their Hydroxylamine Metabolites[NCT00000826] | Phase 1 | 48 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fluconazole and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
Rifabutin-associated uveitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Clinical Trials as Topic; Drug Interaction | 1995 |
Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Age | 1997 |
10 other studies available for fluconazole and Infection, Mycobacterium avium-intracellulare
| Article | Year |
|---|---|
A novel method of desensitization for fluconazole hypersensitivity in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 2011 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Fluconazole and enhanced effect of rifabutin prophylaxis.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Bacteremia; Drug Synergism; Fluconazole; H | 1994 |
Rifabutin prophylaxis and uveitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Fluconazole; Humans; Male; Middle Aged; Mycoba | 1994 |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus.
Topics: Acute Disease; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Ag | 1996 |
Rifabutin levels may increase with fluconazole during MAC treatment.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antitubercular; Antifungal Agents; Drug Interact | 1996 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as To | 1995 |
Opportunistic infections update.
Topics: AIDS-Related Opportunistic Infections; DNA, Viral; Fluconazole; HIV Infections; HIV-1; Humans; Mycob | 1996 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1996 |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibiotics, | 1996 |